OSIRIS THERAPEUTICS, INC. 4
4 · OSIRIS THERAPEUTICS, INC. · Filed Mar 7, 2016
Insider Transaction Report
Form 4
Montgomery Bobby Dwayne
Chief Business Officer
Transactions
- Award
Incentive Stock Option (right to buy)
2016-03-04$7.39/sh+10,000$73,900→ 47,500 totalExercise: $7.39From: 2017-03-04Exp: 2025-03-04→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Options to purchase 10,000 shares of the common stock of the Registrant shall become exercisable with respect to the underlying shares as to 25% on each March 4, 2017, 2018, 2019, 2020, assuming the Reporting Person continues to be employed by the Registrant on the vesting date.